Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

OBJECTIVE: To assess the efficacy and safety of transdermal rivastigmine for the treatment of HIV-associated cognitive impairment. METHODS: We recruited HIV-infected patients with cognitive impairment on stable antiretroviral therapy in a randomized controlled pilot trial with a 48-week follow-up. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Moreno, Jose A., Prats, Anna, Moltó, José, Garolera, Maite, Pérez-Álvarez, Núria, Díez-Quevedo, Crisanto, Miranda, Cristina, Fumaz, Carmina R., Ferrer, Maria J., Clotet, Bonaventura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576750/
https://www.ncbi.nlm.nih.gov/pubmed/28854283
http://dx.doi.org/10.1371/journal.pone.0182547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576750/
https://www.ncbi.nlm.nih.gov/pubmed/28854283
http://dx.doi.org/10.1371/journal.pone.0182547

Ejemplares similares